Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Oct 17, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 14.3B USD
- Positions
- 235
- Share of the ten largest
- 44.0%
The ten largest positions Q3 2022
- Tesla, Inc. 7.5%▼ −5.8%
- Zoom Video Communications Inc 5.6%▲ +13.7%
- Roku Inc 4.7%▲ +17.5%
- UiPath Inc 4.1%▲ +22.6%
- Exact Sciences Corp 4.0%▲ +17.3%
- Intellia Therapeutics Inc 3.8%▲ +1.5%
- CRISPR Therapeutics AG 3.8%▼ −15.3%
- Teladoc Health Inc 3.7%▲ +2.8%
- Block, Inc. 3.5%▲ +0.6%
- Coinbase 3.5%▼ −13.8%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q3 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Zoom Video Communications Inc | 5.6% | 10,891,340 | 801.5M USD | +13.7% increased | Q4 2020 8 quarters |
| Roku Inc | 4.7% | 11,917,866 | 672.2M USD | +17.5% increased | Q2 2019 14 quarters |
| UiPath Inc | 4.1% | 46,084,074 | 581.1M USD | +22.6% increased | Q2 2021 6 quarters |
| Exact Sciences Corp | 4.0% | 17,561,702 | 570.6M USD | +17.3% increased | Q3 2020 9 quarters |
| Intellia Therapeutics Inc | 3.8% | 9,657,052 | 540.4M USD | +1.5% increased | Q4 2016 or earlier 24 quarters |
| Teladoc Health Inc | 3.7% | 20,858,302 | 528.8M USD | +2.8% increased | Q3 2017 21 quarters |
| XYZ Block, Inc. | 3.5% | 9,191,790 | 505.5M USD | +0.6% increased | Q4 2016 or earlier 24 quarters |
| TWLO Twilio | 3.3% | 6,826,631 | 472.0M USD | +22.5% increased | Q4 2018 16 quarters |
| Ginkgo Bioworks Holdings Inc | 2.8% | 126,818,856 | 395.7M USD | +45.2% increased | Q3 2021 5 quarters |
| Unity Software Inc | 2.5% | 11,263,159 | 358.8M USD | +22.7% increased | Q3 2020 9 quarters |
| RBLX Roblox | 2.1% | 8,474,696 | 303.7M USD | +14.4% increased | Q1 2021 7 quarters |
| Fate Therapeutics Inc | 1.8% | 11,655,833 | 261.2M USD | +1.6% increased | Q2 2019 14 quarters |
| Twist Bioscience Corp | 1.6% | 6,676,908 | 235.3M USD | +6.5% increased | Q2 2019 14 quarters |
| Pacific Biosciences of Califor | 1.2% | 28,692,494 | 166.6M USD | +2.3% increased | Q3 2019 13 quarters |
| Veracyte Inc | 1.1% | 9,081,363 | 150.8M USD | +2.5% increased | Q4 2016 or earlier 24 quarters |
| 10X Genomics Inc | 0.9% | 4,576,814 | 130.3M USD | +27.0% increased | Q2 2020 10 quarters |
| TuSimple Holdings Inc | 0.9% | 16,099,348 | 122.4M USD | +18.7% increased | Q2 2021 6 quarters |
| Verve Therapeutics Inc | 0.8% | 3,393,859 | 116.6M USD | +66.8% increased | Q2 2021 6 quarters |
| CareDx Inc | 0.7% | 5,787,120 | 98.5M USD | +44.8% increased | Q2 2019 14 quarters |
| Schrodinger Inc/United States | 0.7% | 3,764,707 | 94.0M USD | +27.5% increased | Q2 2020 10 quarters |
| Invitae Corp | 0.5% | 30,468,381 | 75.0M USD | +6.3% increased | Q4 2016 or earlier 24 quarters |
| Adaptive Biotechnologies Corp | 0.5% | 9,336,619 | 66.5M USD | +6.4% increased | Q2 2020 10 quarters |
| 908 Devices Inc | 0.4% | 3,775,194 | 62.1M USD | +4.1% increased | Q4 2020 8 quarters |
| Butterfly Network Inc | 0.4% | 10,840,899 | 51.0M USD | +52.8% increased | Q1 2021 7 quarters |
| Velo3D Inc | 0.3% | 11,042,242 | 43.5M USD | +2.9% increased | Q3 2021 5 quarters |
| TER Teradyne | 0.3% | 552,318 | 41.5M USD | +24.1% increased | Q4 2016 or earlier 24 quarters |
| Recursion Pharmaceuticals Inc | 0.2% | 3,359,811 | 35.7M USD | +23.0% increased | Q2 2021 6 quarters |
| Markforged Holding Corp | 0.2% | 16,639,680 | 32.9M USD | +20.4% increased | Q3 2021 5 quarters |
| 3D Systems Corp | 0.2% | 3,872,253 | 30.9M USD | +5.4% increased | Q4 2016 or earlier 24 quarters |
| Monday.com Ltd | 0.2% | 261,749 | 29.7M USD | +10.6% increased | Q3 2021 5 quarters |
| Global-e Online Ltd | 0.2% | 995,735 | 26.6M USD | +22.6% increased | Q1 2022 3 quarters |
| Toast Inc | 0.2% | 1,552,023 | 26.0M USD | +7.2% increased | Q3 2021 5 quarters |
| Bill.com Holdings Inc | 0.2% | 168,018 | 22.2M USD | +7.7% increased | Q1 2021 7 quarters |
| Zymergen Inc | 0.1% | 7,482,047 | 20.8M USD | +116.5% increased | Q2 2021 6 quarters |
| ATAI Life Sciences NV | 0.1% | 6,138,914 | 20.3M USD | +279.2% increased | Q1 2022 3 quarters |
| Nurix Therapeutics Inc | 0.1% | 1,286,522 | 16.8M USD | +65.2% increased | Q4 2021 4 quarters |
| Personalis Inc | 0.1% | 5,446,512 | 16.2M USD | +1.8% increased | Q2 2019 14 quarters |
| INTU Intuit | < 0.1% | 30,788 | 11.9M USD | +3.5% increased | Q2 2017 22 quarters |
| Z Holdings Corp | < 0.1% | 4,519,214 | 11.9M USD | +13.7% increased | Q4 2019 12 quarters |
| ISRG Intuitive Surgical | < 0.1% | 54,304 | 10.2M USD | +21.1% increased | Q2 2018 18 quarters |
| GM General Motors | < 0.1% | 259,195 | 8.3M USD | +71.6% increased | Q2 2022 2 quarters |
| FARO Technologies Inc | < 0.1% | 234,583 | 6.4M USD | +26.6% increased | Q4 2016 or earlier 24 quarters |
| Surface Oncology Inc | < 0.1% | 6,035,691 | 6.3M USD | +8.6% increased | Q3 2020 9 quarters |
| ADBE Adobe Inc. | < 0.1% | 22,654 | 6.2M USD | +5,909.0% increased | Q4 2021 4 quarters |
| Desktop Metal Inc | < 0.1% | 2,363,523 | 6.1M USD | +22.7% increased | Q1 2021 7 quarters |
| Rocket Lab USA Inc | < 0.1% | 864,987 | 3.5M USD | +3,934.5% increased | Q1 2022 3 quarters |
| BICO Group AB | < 0.1% | 1,297,756 | 3.5M USD | +217.9% increased | Q3 2021 5 quarters |
| Wix.com Ltd | < 0.1% | 36,392 | 2.8M USD | +39.8% increased | Q4 2017 20 quarters |
| Teva Pharmaceutical Industries | < 0.1% | 335,468 | 2.7M USD | +44.3% increased | Q4 2017 20 quarters |
| CyberArk Software Ltd | < 0.1% | 17,393 | 2.6M USD | +25.3% increased | Q4 2017 20 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 94 positions.
Plus 15 option positions, value of the underlying shares as reported 2.7M USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- Zoom Video Communications Inc Call 692.0K USD
- Tesla, Inc. Call 398.0K USD
- Energy Select Sector SPDR Fund Put 396.0K USD
- ARK Innovation ETF Call 317.0K USD
- Coinbase Call 161.0K USD
- DraftKings Call 150.0K USD
- Block, Inc. Call 148.0K USD
- SomaLogic Inc Call 132.0K USD
- CRISPR Therapeutics AG Call 85.0K USD
- ARK Genomic Revolution ETF Call 72.0K USD
Breakdown by sector
- Financials 9.4%
- Consumer Discretionary 7.7%
- Technology 6.3%
- Health Care 1.8%
- Industrials 1.0%
- Communication Services 0.2%
- not in our coverage 73.7%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors